The world's oceans cover more than 70% of the planet's surface and are home to an incredibly diverse array of microorganisms. These microorganisms produce a vast array of small molecules, many of which have the potential to be used in medicine, agriculture, and industry. For example, some ocean microorganisms produce compounds that have antibiotic properties, while others produce pigments that can be used in cosmetics.
While the potential of ocean microbiome small molecules is enormous, tapping into this potential is not without its challenges. One of the biggest challenges is simply finding the right molecules. With so many microorganisms producing so many different small molecules, it can be difficult to know where to start.
Ross Youngs, the founder and CEO of Biosortia, is tapping into this potential by exploring the ocean's microbiome and uncovering the power of its small molecules. Ross has developed sophisticated screening techniques that allow them to identify promising molecules more quickly and efficiently.
In this chapter, we'll take a closer look at Youngs' work and explore how he's unlocking nature's pharmacy.
To know more about Ross Youngs and Biosortia please follow him on LinkedIn or visit his company website https://biosortia.com/